| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 4)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Neuroendocrine (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 4)
Carcinoma, Transitional Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Disease Progression (Phase 2)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 4)
Head and Neck Neoplasms (Phase 3)
Histiocytoma, Malignant Fibrous (Phase 2)
Kidney Neoplasms (Phase 1)
Liver Neoplasms (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, T-Cell (Phase 2)
Melanoma (Phase 3)
Microsatellite Instability (Phase 1)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Diseases (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Squamous Cell (Phase 3)
Sarcoma (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Thrombosis (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urologic Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue